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ABSTRACT 
 
 
 
 
Bone fracture is a common injury because of its nature position that is mostly closest to 
skin and exposed to excessive compression and depression. Current treatment for bone 
fracture employs the scaffolding approaches which are specifically positioned for a 
certain period of time. These allow the defective bones to undergo proper healing 
processes. However, these scaffolds have two issues that need to be addressed; the 
material’s compatibility and degradability. Previously, there was poor interaction 
between the Chitosan (CS) and Hydroxyapatite (HA)/nano HA (nHA) phases causing 
the composite to have poor physico-chemical properties. This research used 
Carboxymethylcellulose (CMC) as the reinforcement material for CS / HA or nHA 
composite scaffold. The main objective is to produce CMC from Oil Palm Empty Fruit 
Bunch (OPEFB) for temporary biodegradable bone scaffold from a combination of 
CMC, CS and HA/nHA. Series of experiments were done including extracting CMC 
from the OPEFB, fabricating composite scaffold by a co-solution method followed by 
freeze-drying approach to produce a porous bone implant. The final procedure was to 
analyse the CMC and scaffold produced by various analyses and tests including FTIR, 
SEM, EDX, TGA and compressive-modulus for its mechanical characteristics. The 
findings indicated that the strength has increased within 32 – 50 kPa with CMC content 
compared to chitosan scaffold alone which was only recorded at 0.042 – 0.7 kPa. With 
the additional of Calcium Phosphate the results only recorded from 0.024 kPa until 2 
kPa. The composite scaffold was also successfully constructed with lots of pores, 
allowing the scaffold to demonstrate preferential proliferation and extracellular matrices 
and generate mineralised bones. The investigation was extended to in-vitro test 
involving Simulated Body Fluid (SBF) solution to evaluate the biodegradation rate and 
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the growing of apatite layer during immersion. The implant had exhibited 
biodegradation feature parallel to new bone formation. The ability in attracting Calcium 
(Ca) and Phosphate (P) elements for apatite layer development on its surface was also 
proven with the calculated value of Ca/P ratio that has identical value with the theory, at 
1.67.  
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ABSTRAK 
 
 
 
 
Patah tulang adalah kecederaan biasa kerana kebiasaannya, ianya terletak paling dekat 
dengan kulit menyebabkan pendedahan yang melampau pada tekanan yang tidak 
disengajakan. Rawatan terkini untuk patah tulang menggunakan pendekatan perancah 
yang berada pada kedudukan yang khusus untuk tempoh masa yang tertentu. Ini 
membolehkan tulang yang rosak untuk menjalani proses penyembuhan semula. Walau 
bagaimanapun, perancah ini mempunyai dua isu yang perlu ditangani; keserasian bahan 
dan degradasi. Sebelum ini, wujud interkasi yang lemah di dalam fasa antara Chitosan 
(CS) dan Hydroxyapatite (HA) / nano HA (nHA) menyebabkan komposit mempunyai 
ciri-ciri fiziko-kimia yang lemah. Kajian ini menggunakan carboxymethylcellulose 
(CMC) sebagai pengukuh untuk CS / HA atau nHA perancah komposit. Objektif utama 
adalah untuk menghasilkan CMC dari Minyak Sawit Tandan Buah Kosong (OPEFB) 
untuk perancah tulang sementara yang boleh terbiodegradasi sendiri daripada gabungan 
CMC, CS dan HA / nHA. Beberapa siri eksperimen telah dilakukan termasuk 
mengekstrak CMC dari OPEFB, merekabentuk perancah komposit dengan kaedah co-
solution diikuti oleh pendekatan beku-pengeringan untuk menghasilkan implan tulang 
yang berliang. Prosedur akhir adalah untuk menganalisis CMC dan perancah komposit 
yang dihasilkan melalui pelbagai analisis dan ujian termasuk FTIR, SEM, EDX, TGA 
dan mampatan-modulus untuk ciri-ciri mekanikal. Dapatan kajian menunjukkan bahawa 
kekuatan ini telah meningkat di antara 32-50 kPa bersama kandungan CMC berbanding 
perancah chitosan sahaja hanya direkodkan pada 0,042-,7 kPa. Dengan tambahan 
Kalsium fosfat keputusan hanya direkodkan daripada 0,024 kPa sehingga 2 kPa. 
Perancah komposit ini juga telah berjaya dibina dengan banyak liang, membolehkan sel-
sel tulang untuk memulakan percambahan dan matriks extracellular 
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dan menjana semula tulang yang baru. Siasatan itu telah dilanjutkan kepada ujian in-
vitro yang melibatkan larutan Simulated Body Fluid (SBF), kaedah untuk menilai kadar 
biodegradasi dan pertumbuhan lapisan apatite semasa rendaman. Implan tersebut telah 
menunjukkan cirri-ciri biodegradasi selari dengan pembentukan tulang baru. Keupayaan 
dalam menarik Kalsium (Ca) dan fosfat (P) elemen untuk pembangunan lapisan apatite 
di permukaannya juga dibuktikan dengan mengira nisbah Ca/P yang mempunyai nilai 
yang sama dengan teori, pada 1.67. 
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background 
 
Bone is notably created to support and protect various organs in a body. It produces 
red and white blood cells and also stores minerals for living things; humans and 
animals. Mechanical functions of bones are for protection where bones protect 
internal organs. For instance, the skull is protecting the brain and the ribs are 
protecting the heart and lungs. In addition, bones also provide a structural body 
frame to keep the body supported. 
Dynamically, as referred to the web from The Cleveland Clinic Foundation 
(2013), bones trigger movement for the body, where it provides a leverage system for 
skeletal muscles, tendons, ligaments, and joints function together to generate and 
transfer forces. So, individual body parts or the whole body can be manipulated in 
three dimensional spaces. It obviously shows that bones are an eventful structure for 
all living things for survival to execute daily and routine activities.   
The characteristics of bones are very interesting and unique. It bends when it 
receives sudden, unpredictable forces up to its own limitation (Riggs & Melton, 
1995). However, bones are prone to impact from unwanted forces. If the forces 
exerted against a bone exceeded its limit, bones could not withstand the forces and 
starts to break. This phenomenon occurs as bones are only covered with very thin 
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skin and less fat surrounding them, hence provide them with little absorption during 
higher impact events. Despite easily crack problems, bones are able to regenerate and 
redeveloped (Yamamuro, 1995). The newly generated bones provide the same functions 
and strength as normal bones. Bone regeneration is a continuous process and happens 
for an entire life. Unfortunately, the regeneration process decreases slowly with the 
addition of age. 
Bone healing is a complex process. The time required for ossification or process 
of bone healing are dependent and can be affected by many factors including types of 
bone fracture and dependent on the patient’s age and their nutritional status (Alvarez & 
Nakajima, 2009) . Since bone healing is a natural process, the period of time taken to 
cure is of concern. Therefore, several proactive curings are taken to assist the process of 
bone healing. 
Autograft and allograft techniques are frequently used in order to overcome the 
bone fracture problem. Autograft is a technique of replacing the fractured bone with the 
healthy bone from the same person. The advantages of autograft are it provides bone 
cells and growth factors that are essential for healing and bone regeneration, no risk of 
disease transfer and no risk of rejection (Silber et. al., 2003; Myeroff & Archdeacon, 
2011; Oppenheim, Segal & Spitzer, 2002). Despite the advantages of autograft, the 
patients are required to have double surgical operations from two different sites in the 
same body host. This caused double pain to the patients as well as increasing the 
traumatic experiences of the patients (Valliant & Jones, 2011).  
As for options, allograft technique is introduced. This technique involves the 
bone transplant from different host or a bone bank. Allograft provides safer alternative 
to patients who are at higher risk of complications under anesthesia. The surgeon would 
not take a long time to harvest and prepare the autograft, complete the reconstruction 
faster thus avoid having longer period of surgery (Mahony & Jones, 2008). 
Synthetic bone graft substitution brings new phenomena in orthopaedic and 
tissue engineering after more findings were discovered as an effort in curing the bone 
defect. Moore, Graves & Bain (2001) quoted that a variety of synthetic bone graft 
substitutes have been developed during the past 30 years with the aim to minimize the 
risk of postoperative infection and fractures as well as the potential risk of disease 
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transmission as it is from synthetic origin. Moreover, synthetic bone grafts also 
contribute in osteoinductive and osteostimulative (osteointegration) (Moore et. al., 2001)  
which is an essential attribute for bone regeneration stage, offering biodegradable 
properties, an ample supply for bone substitute and available in a wide range of size and 
shape. Unfortunately, most synthetic bone grafts do not provide sufficient mechanical 
strength like ceramics and they are not osteogenic.  
Another type of bone treatment is by metallic implants. In this process, metal 
plates were used rather than the actual bones. Normally, metal plates used were stainless 
steel and titanium and Cobalt based alloys (Schmutz, Quach-Vu & Gerber, 2008). They 
show a high corrosion resistance due to their stable passive layer. However, they also 
have some benefits; superior in mechanical properties such as hardness and stiffness 
compared to other materials such as polymer and visible during x-ray (Schmutz et. al., 
2008).  Metallic implants were used in many treatments and were fairly successful, but 
problems related to stress shielding during post-healing and fatigue and loosening of the 
implant limit its function. Moreover, second surgery is usually required in order to 
remove the metallic implant after healing, and it increases the risk of the operation and 
the expense to the patient (Middleton & Tipton, 2000). 
The above treatments have mentioned several benefits and drawbacks of the 
treatments. It has been a desire for biodegradable implants to be developed that will 
eventually biodegrade itself.  Upon degradation process, ion releases are able to 
encourage surrounding cells to form new bone formation more rapid at a preferred rate.  
According to Pilliar et. al. (2001), the controllable rate of new bone formation is 
necessary in order for the defect site to eventually be replaced by a newly formed natural 
bone and strong enough to fulfil required load-bearing. The new bone can at least be 
functional during the early stage of the post - implantation period, before significant 
bone ingrowth and the replacement has occurred.  
Most metallic materials are not biodegradable, which bring polymeric materials 
more benefits than the metal implants because it eliminates the need for a second 
operation and can prevent some problems associated with stress shielding. Sundararajan, 
Ma & Howard (1999), Pilliar et. al. (2001), Langer & Vacanti (1993), Hubbel (1995), 
Hellman (1997) and Niklason & Langer (1997) have stated that the tissue engineering 
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approach to repair and regenerate is founded upon the use of polymer scaffolding which 
serve to support, reinforce and in some cases organize the regenerating tissue. So, the 
reconstruction of new bone is more effective and well organized. 
There is a need for the development of new biodegradable materials to be used in 
orthopaedics and as scaffolding for hard tissue enginnering (Mano et. al., 1999). 
Polymers are often used as matrix in bone scaffold composite. For example, 
lignocellulosic fibers obtained from renewable resources where it is composed from 
carbohydrate polymers is one of the example of natural polymer. An example of 
carbohydrate polymer is cellulose. It is the abundant renewable resource that has become 
of more and more interest as reinforcement in composites. This is because they are 
biodegradable and harmless for the ecological system. Furthermore, they have promising 
mechanical properties and are less expensive than conventional synthetic polymers 
(Zimmermann, Pohler & Geiger, 2004). 
 
 
1.2 Problem Statement 
 
Bones are important organs to ensure smooth movement for daily activities but it is 
prone to get fractured since it is surrounded by thin skin and less fat. That makes it 
easily exposed to get harmed. Bone implant is the second most replaced organ in the 
body after blood where approximately 2.2 million bone graft procedures are performed 
worldwide each year (Giannoudis, Dinopoulos & Tsiridis, 2005). Moreover, the 
estimated cost of these procedures approaches $2.5 billion per year (Desai, 2007). While 
bone transplantation and tissue reconstruction are highly successful therapies for a 
variety of bone diseases and fracture problems, a shortage of donor bone tissue limits 
their application (Jones & Hench, 2001). 
Due to the serious circumstances, the vital alternative is to create an implant 
fabricated from synthetic and also natural sources. Extracellular matrices (ECMs) of 
hard tissue are composed of organic (collagen type I and small amount of GAGs-
glycosaminoglycans) and inorganic phases (mainly nano hydroxyapatite crystals – nHA) 
(Zhao et. al., 2002).  
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Nano scale HA is known to own excellent biocompatibility based on its close 
chemical and crystal resemblance to bone material (Hench, 1998; Suchanek & 
Yoshimura, 1998; Gomez-Vega et. al., 2000). While that, chitosan (CS) can accelerate 
the bone formation because of the similarity to GAGs in structure (Seol et. al., 2004; Di, 
Sittinger & Risbud, 2005; Madihally & Matthew, 1999; Yamane et. al., 2005; Loke et. 
al., 2000).  
However, there is a poor interaction between CS and HA/nHA phases causing 
the composite to have poor physico-chemical properties. Due to the fact that normally, 
for interface improvement between HA/nHA and CS, the second organic polymer acts as 
reinforced phase in HA/nHA-based composite is essential (Jiang, Li & Xiong, 2009b). 
Carboxymethyl cellulose (CMC) possesses very similar structure to CS structure which 
creates strong ionic cross-linking action between CMC and CS (Xiao et. al., 2006; Qiu 
& Li, 2005). This evidence has been supported by Latif, Anwar & Noor (2007) as shown 
in Fig. 1.1. 
 
 
Figure 1.1: The chemical structure of (a) CMC, and (b) Chitosan (Latif et. al., 2007) 
 
Briefly, CMC, also known as cellulose gum, is a cellulose derivative with 
carboxymethyl groups (-CH2-COOH). The functional group is bound to some of the 
hydroxyl groups (-OH) of the glucose monomers that make up the cellulose backbone.  
(a) 
(b) 
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The availability of CMC sources is undoubted. In this research, it was extracted 
from Oil Palm Empty Fruit Bunch (OPEFB). Empty Fruit Bunch (EFB) from palm oil  
waste is a potential raw material. This is because palm oil has made an impressive and 
sustained growth in the global market over the past four decades, and it is projected that 
in 2016-2020, the average annual production of palm oil in Malaysia will reach 15.4 
million tonnes (Teoh, 2000; Abdullah & Sulaiman, 2013). 
Sulaiman et. al. (2010) indicated that large amount of oil palm residues that can 
be re-utilised were dumped. This resulted in millions of ringgit energy value wasted 
each year with approximate loss of about 6,379 million ringgit (Sulaiman et. al., 2010). 
Due to the environmental concerns over properly disposing the waste,  OPEFB could be 
converted into useful material in biomedical engineering.  
Therefore, a novel approach of the composite with the additional of CMC as a 
natural polymer in order to reinforce CS and HA was created to address the limitations 
of the previous sample. For the scaffold to integrate with surrounding tissue, it should 
imitate the structure and morphology of the natural bone tissue (Stevens et. al., 2007). 
Thus, there is strong ionic cross-linking action between CMC and chitosan and it is able 
to produce better composite for bone scaffold. The strong ionic cross-linking between 
CMC and chitosan is possible to occur because chitosan is a cationic polymer whereas 
CMC is an anionic polymer where by their combination, a strong ionic bond is created 
to produce stronger composite. 
 
 
1.3 Objective 
 
The aim of this research is to produce CMC from OPEFB as biomaterial for temporary 
bone scaffold reinforced with chitosan and HA/nHA. In order to achieve the aim, several 
objectives have been highlighted as follow: 
(1) To evaluate and analyse the performance of the OPEFB-CMC as the 
reinforcement material to strengthen chitosan and HA/nHA, as a porous 
composite scaffold, 
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(2) To investigate the strength of composite by compression test and physical 
characteristics, 
(3) To evaluate the degradation time, apatite layer formation, porosity measurement 
and swelling ability through in-vitro test simulation. 
 
 
1.4 Scope of Research 
 
The scope of this research includes: 
(1) To produce CMC that was synthesized from oil palm waste, the empty fruit 
bunch. It was chosen because it dissolved easily in water because in order to 
utilize cellulose widely in any application, cellulose must be converted to soluble 
derivatives. The fabrication process is also at lower cost, easy and safe to 
produce. Analyses involved are FTIR and XRD. 
(2) To produce porous scaffold fabricated from natural polymer and HA/nHA with 
the attendance of chitosan for better physico-chemical properties. 
(3)  To investigate the mechanical properties and focus only on compression test in 
evaluating the effectiveness of CMC as a potential material in bone scaffold. The 
analysis involved is TGA analysis. 
(4) To analyse the morphology of the scaffold including its porosity content either at 
the surface or inside the scaffold. FTIR, SEM and EDX analyses will be 
implemented to examine this.  
(5) To simulate the biodegradation rate of bone scaffold and the growing of apatite 
layer by immersion of samples in Simulated Body Fluid (SBF) liquid for in-vitro 
test.     
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1.5 Contribution to Knowledge 
 
CMC in this research was produced through two different methods from OPEFB. The 
first method was followed by conventional and commercial product processes. It used 
aqueous Sodium Hydroxide (NaOH) for cellulose activation. Improvement in fabricating 
process of CMC using solid NaOH approach for cellulose activation with the 
polysaccharide was priorly dissolved in Tetrabutylammonium Flouride 
(TBAF)/Dimethyl Sulfoxide (DMSO). So, there is no requirement to use aqueous NaOH 
to obtain CMC  with higher Degree of Substitution (DS). 
Conventionally, CMC wide application was in fields of membrane separation, 
coating, film and textile (Fauzi, Wan Daud & Mohamad Ibrahim, 2014) while CMC is 
famous in the application of food, pharmaceuticals, toothpaste, detergents, oil drilling 
mud, paper coating (Ambjornsson, Schenzel & Germgard, 2013; Stigsson, Kloow & 
Germgard, 2001) and others. This research attempts to use the material in orthopaedic 
applications for temporary bone scaffold. The manufacturing of the product itself was 
very environmentally friendly since no chlorine was involved during bleaching process, 
easy and safe to produce in the laboratory.  
 The scaffold fabrication by previous co-solution method added all the materials 
together in distilled water before uniformly agitated on hotplate. Since OPEFB-CMC 
state is not identical to commercial products, a new method has been developed. In order 
to dissolve and uniformly disperse the OPEFB-CMC in distilled water, there is a 
requirement to sonicate it before mixed with other materials. This resulted in more 
strength composite.   
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1.6 Organization of Thesis 
 
This thesis contains six chapters. Chapter 1 is the introduction explaining briefly about 
the background, problem statement, objective, scope and contribution of the research. 
Chapter 2 explains the literature review of current and latest studies. This 
includes explanation about bone structure, problems involving bones, the materials 
commonly used for bone tissue engineering, fabricating of bone implant and some 
review about the analyses and tests for bone scaffold.   
Chapter 3 describes the methodology carried out during the experimental work. It 
comprises of generally two main parts which are materials used and procedures in 
fabricating bone scaffolds.  
Chapter 4, provide the results and discussions of characterization of CMC from 
oil palm waste, the empty fruit bunch. 
Chapter 5 is the analysis results for porous bone scaffold fabricated from the 
combination of organic materials which are chitosan and CMC and inorganic material, 
hydroxyapatite and its nano size.  
Chapter 6 is the final chapter of the thesis consisting of the conclusion and future 
recommendations. It summarizes the overall findings from the experiments done. The 
conclusions reflected the achievements of the listed objectives obtained throughout the 
study. Finally, future recommendations for the research are listed for improvement of 
future study in the same field of study. 
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CHAPTER 2 
 
 
 
 
LITERATURE REVIEW 
 
 
 
 
This chapter discusses some important features related to previous works done by other 
researchers. This includes the literature reviews on tissue engineering, bone fractures, 
materials used for bone replacements as well as the procedures of bone generations. This 
chapter gives some information for readers on the research conducted herein.  
 
 
2.1 Introduction 
 
The conjunction of a combination of cells, engineering and materials methods, together 
with suitable biochemical and physico-chemical features to improve or replace 
biological functions are known as Tissue Engineering (TE) technology. It has gained so 
much attention since it used the combination of biology, engineering and material 
science in providing suitable biochemical and physiochemical factors to achieve better 
improvement while replacing biological functions. TE involves attempts to mimic 
specific biochemical and physical functions combining cells within artificially-created 
support systems (Carrico et. al., 2008).  
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Engineering factors are commonly associated with the repair or replacement of 
tissue portions or the whole tissue itself, for example, bone, cartilage, blood vessel, etc.  
It includes the mechanical and structural properties to operate properly. The concept is 
that tissues and organs can be “engineered” to be used for transplantation, which could 
provide revolutionary and stimulating for self healing.  
All inclusive explanation involving TE applied to bone based on natural sources 
is the main focus of this research. This begins with a brief explanation on bone 
constitution and characteristics, followed by more detailed clarification on material 
selection, production of scaffolds  and important features necessary to produce good 
scaffold to be used as temporary bone implant. The scaffold will be evaluated through 
several analyses and tests to clarify its effectiveness.  
 
 
2.2 Bone and Bone Tissue 
 
Bones  are the rigid organs that form parts of the endoskeleton of vertebrates that 
function to move, support and protect such vital organs. It is an excellent and inimitable 
structural composite (Mobini et. al., 2012) composed of two major phases; collagen 
fibers, serves as an organic matrix with biological apatite precipitated along the collagen 
fibrils as reinforcing constituent (Park & Larks, 2007; Murugan & Ramakrishna, 2005; 
Mobini et. al., 2012; Ramakrishna et. al., 2001; Olah et. al., 2006) as shown in Fig. 2.1, 
designed by nature. The high elastic modulus hydroxyapatite mineral comprises 
approximately 70% of the dry bone mass and contributes significantly to the bone 
stiffness (Olah et. al., 2006). 
Since bones are original composite, it has also come in a variety of shapes and 
have a complex internal and external structure. They possess special attributes such as 
lightweight, yet strong and hard. Moreover they have to fulfil many other functions 
including mineral storage, acid-base balance, detoxification and sound transduction 
(Carrico et. al., 2008).   
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(a) (b) 
    
Figure 2.1: (a) Macroscopic features of bone structure: (A) cancellous bone; (B) cortical 
bone, (b) Composition of the bone in volume percent (Ramakrishna et. al., 2001; Olah 
et. al., 2006). 
 
The tissue that constructs the bone is a mineralized tissue constituted by 
hydroxycarbonate apatite (HCA); the mineral that gives it the necessary rigidity, some 
other proteins and a matrix structured protein (collagen fibrils) that provides tensile 
strength and toughness (Mahony & Jones, 2008; Stevens & George, 2005). 
About 99% calcium content makes bone as a reservoir for calcium in the body. 
Bone mineral is mostly (85%) in the form of hydroxyapatite (HA, Ca10(PO4)6(OH)2), 
with calcium carbonate (10%), calcium fluoride (2%–3%) and magnesium fluoride (2%–
3%) (Polo-Corrales, Latorre-Esteves & Ramirez-Vick, 2014). The chemical composition 
in bone is as exhibited in Table 2.1 (Liebschner & Wettergreen, 2003). 
 
Table 2.1: Composition of major chemicals in bone (Liebschner & Wettergreen, 2003) 
Chemical composition of bone Percentage (%) 
Calcium 26.7 
Phosphorus 12.47 
Carbonate 3.48 
Sodium 0.731 
Magnesium 0.436 
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2.2.1 Compact and spongy bone 
 
The cross section of bones shown in Fig. 2.2 presents the transparent area of bone 
(Stevens, 2008). Compact bone is tightly packed, situated at the outer layer which nearly 
approaches the solid state of bone. It contributes 80% of the total bone mass of an adult 
skeleton and contains 5% – 30% of pores. This tissue, also known as a dense bone due to 
its minimal gaps and spaces, gives bones their smooth, white and solid appearance.  
 
 
Figure 2.2: Cross-section of bone (Stevens, 2008) 
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The remaining 20% bone mass is from spongy bones since it contains a lot of 
pores (sponge look-alike), estimated between 30% – 90%, with nano size where the 
regeneration of new bone formation begins here. In trabeculae, it corresponds to the 
areas with the lacuna (void or space) and contains osteocyte, the mature bone cells 
besides having nerves and veins for blood circularization and providing for cell seeding 
too (Clarke, 2008; Erikson, Axelrod & Melsen, 1994).  
 
 
2.2.1.1 Constitution 
 
The matrix builds up the major constituent of bone surrounding the cells. The inorganic 
matter in the matrix represents about 50% of its dry weight. Crystalline mineral salts and 
calcium are almost constituted of hydroxyapatite. The organic part of matrix is Type I 
collagen. In terms of mimicking natural tissue, an ideal polymer for tissue scaffolds 
would be type I collagen as it has excellent mechanical properties and comprises over 
90% of the organic component of bone (Iler, 1979; Pereira et. al., 2005; Valliant & 
Jones, 2011).  
The main difference that distinguishes the matrix of a bone from other cell is its 
hardness. The matrix is initially laid down as non-mineralized osteoid (manufactured by 
osteoblasts). Mineralization involves the secretion of alkaline phosphatase by osteoblasts 
vesicles. As referred to web of Boundless, Born (2015), regarding to the cells, there are 
three different types: osteocytes (internal bone cells), osteoblasts (bone creation) and 
osteoclasts (bone resorption).   
Osteocytes, which synthesize the organic components of the matrix (type I 
collagen, proteoglycans and glycoproteins), are exclusively located at the surfaces of 
bone tissue. Some of them, when surrounded by newly formed matrix become 
osteocytes and create an empty space, named lacuna as referred to Fig. 2.2. These 
osteocytes, found each one in a different lacuna, have a kind of extensions – a network 
of thin canaliculi – able to pass molecules from cell to cell. Osteoclasts, which are 
multilnucleated giant cells involved in the resorption and remodeling of bone tissue, are 
derived from the fusion of bone marrow – derived cells, which secret specific  enzymes 
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that promote the digestion of collagen and dissolution of calcium salt crystals (Carneiro, 
2005).  
 
 
2.2.1.2 Histogenesis and bone growth 
 
Bone can be formed in two different ways, there are by direct mineralization of matrix 
secreted by osteoblasts (intramembraneous ossification) or by deposition of bone matrix 
on a pre-existing cartilage matrix (endochondral ossification). In both processes, the 
bone tissue that appears first is primary, or woven. It is a temporary tissue and is soon 
replaced by the definitive lamellar secondary tissue, in a process that allows maintaining 
the bone shape while it grows. The rate of bone remodelling (bone turnover) is very 
active in young children, where it can be 200 times faster than that in adults. Bone 
remodelling in adults is a dynamic physiologic process that occurs simultaneously in 
multiple locations of the skeleton, not related to bone growth (Carneiro, 2005). 
The relevance of bone TE lies on replacing the organism in a function it cannot 
naturally perform. The body’s bone regenerative capacity is insufficient to heal severely 
injured bone portions. 
 
 
2.3 Bone Fracture  
 
In medical, bone failure always refers to bone fracture, a condition of which the 
existence of small cracks or break in the continuous bones. In general, the common 
cause for bone fracture can be summarized as follows (Krucik, 2012): 
1) Traumatized incidents such as a sports injury, vehicle accidents and falls. 
2) Acquired diseases of bone such as osteoporosis. 
3) Anomalies formation of bone in a congenital disease such as osteogenesis 
imperfection and brittle bone disease. 
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Traumatized incidents contributed to more than half problems in the whole 
world. It is commonly caused by activities that place stresses on bones and joints like 
harsh and overwhelming sports and tremendous vehicle accidents. Disease such as 
osteoporosis is also main contributor for bone fracture problem too.  
Jacob et. al. (2008) clarify that osteoporosis is a disease characterized by low 
bone mass and deterioration of bone structure that increases the risk of fracture. It effects 
directly from the unhealthy lifestyle such as lack of daily nutrition taken needed by 
bones to keep healthy.  
Jacob et. al. (2008) also mentioned a rate of 26 in 100 women and 4 in 100 men 
had been told by their doctors they had osteoporosis where the rate show an increment 
than those found a decade earlier due to the increasing of bone mass testing and 
extensive educational and awareness effort. Nevertheless, in 2004, only 16 percent of 
persons admitted to the hospital were diagnosed with osteoporosis proved that 
osteoporosis is significantly under-diagnosed (Jacob et. al., 2008). 
Moreover, a brittle bone disease also known as Osteogenesis Imperfecta presents 
at birth and occur commonly among babies who have a family history of the disease. 
The worst case, it could cause hearing loss, respiratory or heart failure, spinal cord and 
brain stem problems and permanent deformities (Kivi & Solan, 2012).  
Furthermore, the nutritional status is usually directly related to the age of the 
patient. The absorption of nutrient for elderly patient is decreased because the bone is 
going through aging, which resulted in low collagen in the bone that finally causing low 
bone formation. Bonjour, Schurch & Rizzoli (1996) stated that deficiency in both 
micronutrients for example calcium and vitamin D and macronutrients for example 
protein can accelerate age-dependent bone lose, increase the propensity to fall by 
impairing movement coordination and affect protective mechanisms that reduce the 
impact of falling. 
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2.4 Bone Formation 
 
Clearly, bone regeneration naturally occur is continuously for entire life. Fig. 2.3 shows 
general bone formation which clearly shows four stages in bone fracture healing process. 
The stage (1) is the hematoma formation which describes the formation of blood clots 
from blood leakages. During this stage, bone cells without nutrition died. Stage (2) is the 
fibrocartilage formation. During this stage, fibrocartilage callus forms a splint.  Tissues 
with new capillaries are granulated whereas dead tissue is disposed.  The fibrocartilage 
callous forms connective tissue fibres, cartilage and some bony matrix. Stage (3) is 
called the bony callus formation. Here, the osteoblasts and osteoclasts migrate into the 
tissues and divide, replace the cartilage with bony callus. Finally, in the stage (4), 
remodelling of bony matrix according to the stresses placed on bone takes place.  
Permanent patch finally is produced resulted in bone healing completely. 
 
 
Figure 2.3: Stages in the healing of a bone fracture. (1) Hematoma formation, (2) 
Fibrocartilage callus formation, (3) Bony callus formation and finally (4) Bone 
remodelling (Kivi & Solan, 2012) 
 
Due to the advancement in medical treatments, several attempts have been made 
to encourage bone formation during healing processes. This involves with bone graft, 
bone synthetic graft with the assistant of foreign things such as metallic implants, and 
the most recent by using biodegradable and bioactive materials such as polymers and 
ceramics (Hench, 1991).  
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2.5 Bone Graft 
 
Bone graft is one of the famous grafts after blood and skin implant (Valliant & Jones, 
2011). This is another valuable and successful alternative when facing bone failure, such 
as fracture and break. Bone graft is a surgical procedure needed when someone suffered 
bone fracture related problems. It has been confronted with an unlimited amount of 
challenges since the first successful graft had been performed in the 1870’s (Hing, 
Wilson & Buckland, 2007).  There are two prominent techniques in bone grafting 
including allograft and autograft. Apart from these two techniques, synthetic bone graft 
is also of interest when dealing with bone fractures (Bauer, 2007). 
 
 
2.5.1 Allograft  
 
Allograft possesses osteoinductive properties where few mature osteoblasts survive the 
transplantation (Cypher & Grossman, 1996) but adequate numbers of precursor cells do 
(Triffit, 1996). It is from these precursor cells that the osteogenic potential is derived. 
Though it only could be recognized when the graft is utilized in either a morsellized or 
dimineralized form  (Moore et. al., 2001). This is because allograft is a surgical 
operation which takes bone from another person, commonly from elderly, or also from a 
bone bank as the main supplier. However, taking bone from an elderly is quite a risky as 
the mechanical properties are rather low, as a result of decreased protein and collagen 
contained.  
Betz (2002) also has outlined several difficulties arises from having this 
treatment. Since the defect bone was substituted with bone retrieved  from the bone 
bank, there are several issues related to minor immunogenic rejection and disease 
transmissions, which unfortunately still unresolved. These bones have higher risk 
contain less nutrition because in order to lower the risk of disease transmission and also 
rejection, all bones are irradiated to kill all cells, leaving only the bone matrices 
(Valliant & Jones, 2011).  
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Although the risk is low, the probability the bones to get infected (Moore et. al., 
2001) are still there. The irradiation process also damages the collagen structure, which 
causes a severe reduction in terms of the fractures (about 64%) with rate up to 19 
percent (Moore et. al., 2001) and fatigue loading (about 87%) (Costain & Crawford, 
2009). However, the failure percentage depends on the dosage during the irradiation 
process. The bones are also commonly harvested from elderly that cause bone density to 
be low and cause poor mechanical properties (Seebach et. al., 2010). 
Bone bank is more risky with complication such as non-union problem (Moore 
et. al., 2001). Coalition or union of allograft is difficult to assess and inconsistency has 
been found between clinical, radiological and histological union. Costly, time 
consuming bone banking as well as the possible danger of viral and bacterial transmitted 
diseases are disadvantages that were also concluded by Schieker et. al. (2006). 
 
 
2.5.2 Autograft  
 
In avoiding problems created by allograft, autograft is seen as a better curing for its 
availability and avoidance of morbidity by autogenous graft. Autograft is largely useful 
for large bone defects, which require structural support, or when insufficient autogenous 
graft volume is available. The operation provides all three elements for generating and 
maintaining bone tissue, namely osteogenic progenitor cells, osteoinductive growth 
factors, and osteoconductive matrices (Schieker et. al., 2006). However, Schieker and 
his co-workers also mentioned that this method is still restricted due to limited quantity 
and an additional secondary operative procedure.  
Autograft is limited in terms of more operative time, limited availability and 
significant morbidity related to blood loss, wound complications, local sensory loss and 
most importantly, chronic pain as the technique involves double surgery on the same 
host– on the defected and donor sites. Pain persists more than three months on the donor 
site, causing trauma to the patients and it seems proportional to the extent of dissection 
required to obtain the graft. The second site of surgery, which is at the donor site usually 
requires more time to heal as it needs further treatment under maximum supervision.  
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Fig. 2.4 illustrated an example of the autograft treatment for tracheal autograft 
technique (Backer, 2005). Technically, the bone transplant for autograft is identical with 
this procedure. Moreover, rehabilitation process needs more time, essentially necessary 
to fasten the bone curing and encouraging new bone to quickly suit usual activities. 
These are costly which majority of the patients could not afford to cover.  
As described in previous section, both operations related to bone graft have their 
own benefits and drawbacks. Nevertheless, it is essential to create another possible 
alternative for curing bone defect to avoid any problems that would arise later instead of 
being dependant to only these two techniques. Constantino & Freidman (1994) 
altogether with Cypher & Grossman (1996) have stated four characteristics that an ideal 
bone graft material should exhibit which include: 
(1) Osteointegration – the ability to chemically bond to the surface of bone without 
an intervening layer of fibrous tissue, 
(2) Osteoconduction – the ability to support the growth of bone over its surface, 
(3) Osteoinduction – the ability to induce differentiation of pluripotential stem cells 
from surrounding tissue to an osteoblastic phenotype, and 
(4) Osteogenesis – the formation of new bone by osteoblastic cells present within the 
graft material.  
 
 
Figure 2.4: Autograft procedure for tracheal (Backer, 2005)  
Defect site 
Curing at 
defect site 
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2.5.3 Synthetic Bone Graft 
 
The awareness of bone shortage by applying either allograft or autograft technique in 
curing bone defect is making researches around the world to figure out several 
alternatives. The most effective one is by creating a material (other than human sources), 
that could imitate the ability of natural bone. Synthetic is an unnatural substantial made 
artificially from materials like ceramic and glass materials. There is also natural or 
synthetic polymer and the combination of both polymer and ceramic producing stronger 
composites and lighter which are similar to natural bones (Zimmermann et. al., 2011).    
Bauer (2007) said that the material involved with the fabrication of synthetic 
bone graft should have biological properties like osteointegration which has the ability 
to chemically bond with the bone surface. In order to implement the task perfectly, 
osteoinduction which promotes bone formation along its surface when it is placed into 
the bone would take part followed by differentiation of stem cells from surrounding 
tissues into osteoblast cells. Osteoblasts are unique cells designed to support the 
formation of new bones. This is known as osteogenesis. 
Synthetic bone substituting graft appearances are diversified such as in the form 
of bone cement filling, membrane and among them, bone scaffold is the most preferred 
because Chen, Roether & Boccaccini (2008) highlighted that bone scaffold is highly 
porous, three-dimensional (3D) which exhibit tailored porosity, pore size and 
interconnectivity for vascularization. Fig. 2.5 exhibited µCT image of a silica/γ-PGA 
hybrid foam scaffold from previous works (Valliant & Jones, 2011).  
Moreover, porous bone scaffold could priorly seeded with cell culture during in 
vitro activity. The implementation is related to the application of a tissue-engineered 
implant surface to permanently stabilize implants by coating the prosthesis with cells or 
tissue before implantation (Burg, Porter & Kellam, 2000). Reconstructive orthopaedic 
surgeries took credit with this benefit because it always have high possibility incidences 
of failure secondary to large bone defect (Burg et. al., 2000; Dekker et. al., 1998). 
 
 
22 
 
 
 
Figure 2.5: Porous bone scaffold (Valliant & Jones, 2011) 
 
However, porosity and pore structure are the key parameters which are 
determining the properties and the applicability of scaffolds for tissue engineering. In 
Fig. 2.6 shows a summary of different functions related to the pore structure that must be 
tailored to the particular tissue under consideration (Boccaccini & Maquet, 2003). 
 
 
Figure 2.6: Schematic diagram showing the different functions of a tissue engineering 
scaffold depending on its porosity and pore structure (Boccaccini & Maquet, 2003) 
Sufficient pore volume: tissue expansion
Spatial pore orientation and continuity: 
reconstruction of tissue framework
Macropores (100µm): cell infiltration, 
invasion of blood vessels, building of 
tissue layers. 
Micropores (10-50µm): cell adhesion, 
diffusion of oxygen and nutrients, waste 
clearance
Mechanical stability
Physical properties of 
porous scaffolds
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It is a tricky and challenging task to fulfil all the essential requirements in 
producing good porous scaffold. All important aspects should take into consideration 
that would related from the materials chosen, fabricating process, the design and not to 
forget the characteristics in developing a scaffold that will be explained in detail in the 
next section. 
 
 
2.6 Development of Scaffolds 
 
The development in fabricating scaffolds indicate positive improvement since it was first 
invented decades ago (Gösta, 2000). Several important attributes are taken into 
consideration such as the characteristics of the bone scaffold, the materials chosen, 
scaffold architecture and its fabrication with the main aim is to produce a tough even 
having high porosity content.   
 
 
2.6.1 Characteristics 
 
Vascularization is essentially necessary because large scaffolds need blood vessels for 
successful bone regeneration. Blood vessels can be grown in vitro prior to implantation 
so they will connect the host vessels after implantation. To achieve that, stem cells and 
endothelial cells were seeded inside a gel and scaffolds were soaked in it for about one 
day for veins to be traced. 
An ideal bone scaffold should at least exhibit some of these general attributes 
(Jones, Lee & Hench, 2006; Jones, Gentlemen & Polak, 2007; Jones et. al., 2009): 
1) Act as a template for bone growth in 3D and has an interconnected pore structure 
to allow 3D bone ingrowth. 
2) Resorbs at the same rate as the bone is repaired, producing degradation products 
that are non-toxic and that can be excreted easily  by the body. 
3) Biocompatible (non-toxic) and promotes cell adhesion, stimulating new bone 
growth (osteogenesis). 
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4) Bonds to the host bone without the formation of scar tissue, creating a stable 
interface. 
5) Exhibit mechanical properties matching those of the host bone after in vitro 
tissue culture. 
6) Made from a processing technique that can produce irregular shapes to match 
that of the bone defect. 
7) Has the potential to produce commercially and sterilized to the required 
international standards for clinical use. 
  
 
2.6.2 Biomaterials: Synthetic and Natural 
 
Synthetic is defined as something that chemically or sometimes naturally made 
exclusively to imitate the natural product. The terminology of biomaterials are product 
that interacts with biological systems. Synthetic biomaterials could be simplified as 
something that synthesized chemically to mimic the natural product so the products 
produced are able to interact with biological system. Materials that synthetically 
synthesized in order to fabricate bone scaffold commonly from metals, ceramics, glass, 
chemically synthesized polymers, natural polymers and combinations of these materials 
to form composites (Karageorgiou & Kaplan, 2005). 
 
 
2.6.2.1 Metal-based biomaterials 
 
In attempting to repair the skeletal systems, surgeons must endeavor to replicate the 
static and dynamic responses of the bone. Bone exhibits a higher flexural strength and 
flexural modulus than polymeric materials but is weaker and more deformable than 
metals (Dunn & Casper, 1985). Therefore, there is vital circumstances in searching the 
most suitable material for temporarily substitute defect bone. 
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